These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19907908)

  • 1. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
    Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
    Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadline.
    Taylor K; Casalegno C; Stengel W
    ALTEX; 2011; 28(2):131-48. PubMed ID: 21625829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 7th Amendment to the Cosmetics Directive.
    Ruet Rossignol M
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of reconstructed skin models in pharmaco-toxicological trials.
    Damour O; Augustin C; Black AF
    Med Biol Eng Comput; 1998 Nov; 36(6):825-32. PubMed ID: 10367477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
    Indans I
    Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S
    ALTEX; 2012; 29(1):1. PubMed ID: 22408846
    [No Abstract]   [Full Text] [Related]  

  • 10. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
    Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
    Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats.
    Bulgheroni A; Kinsner-Ovaskainen A; Hoffmann S; Hartung T; Prieto P
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):16-9. PubMed ID: 18977273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
    Basketter DA; Clewell H; Kimber I; Rossi A; Blaauboer B; Burrier R; Daneshian M; Eskes C; Goldberg A; Hasiwa N; Hoffmann S; Jaworska J; Knudsen TB; Landsiedel R; Leist M; Locke P; Maxwell G; McKim J; McVey EA; Ouédraogo G; Patlewicz G; Pelkonen O; Roggen E; Rovida C; Ruhdel I; Schwarz M; Schepky A; Schoeters G; Skinner N; Trentz K; Turner M; Vanparys P; Yager J; Zurlo J; Hartung T
    ALTEX; 2012; 29(1):3-91. PubMed ID: 22307314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V
    Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
    [No Abstract]   [Full Text] [Related]  

  • 15. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
    Hartung T; Blaauboer BJ; Bosgra S; Carney E; Coenen J; Conolly RB; Corsini E; Green S; Faustman EM; Gaspari A; Hayashi M; Wallace Hayes A; Hengstler JG; Knudsen LE; Knudsen TB; McKim JM; Pfaller W; Roggen EL
    ALTEX; 2011; 28(3):183-209. PubMed ID: 21993956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.
    Almeida A; Sarmento B; Rodrigues F
    Int J Pharm; 2017 Mar; 519(1-2):178-185. PubMed ID: 28104405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019.
    Gustafson E; Debruyne C; De Troyer O; Rogiers V; Vinken M; Vanhaecke T
    Arch Toxicol; 2020 Nov; 94(11):3723-3735. PubMed ID: 32839844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects--2010.
    Balls M; Clothier R
    Altern Lab Anim; 2010 Oct; 38(5):345-53. PubMed ID: 21105753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation.
    Rovida C; Basketter D; Casati S; de Silva O; Hermans H; Kimber I; Manou I; Weltzien HU; Roggen E
    Altern Lab Anim; 2007 Jun; 35(3):317-22. PubMed ID: 17650950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.